Stock comparison
Arcosa, Inc. is 4.0x more valuable than Proto Labs Inc by market capitalization ($7.12 B vs $1.77 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ACA is larger
Arcosa, Inc. is 4.0x more valuable than Proto Labs Inc by market capitalization ($7.12 B vs $1.77 B).
Market value leader
ACA
Arcosa, Inc. is 4.0x more valuable than Proto Labs Inc by market capitalization ($7.12 B vs $1.77 B).
Revenue leader
ACA
PRLB: $533.13M vs ACA: $2.88B.
Profit leader
ACA
PRLB: $21.24M vs ACA: $208.40M.
Margin leader
ACA
PRLB: 4.0% vs ACA: 7.2% net margin.
| Metric | PRLB | ACA |
|---|---|---|
| Market cap | $1.77 B | $7.12 B |
| US-listed rank | #2241 | #1158 |
| Revenue (latest FY) | $533.13M | $2.88B |
| Net income (latest FY) | $21.24M | $208.40M |
| Net margin | 4.0% | 7.2% |
| P/E (trailing FY) | 83.3x | 34.2x |
| SEC filings | 878 | 632 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Arcosa, Inc. is 4.0x more valuable than Proto Labs Inc by market capitalization ($7.12 B vs $1.77 B).
In their latest fiscal years, Proto Labs Inc reported $533.13M in revenue while Arcosa, Inc. reported $2.88B.
Full pages: Proto Labs Inc and Arcosa, Inc., or browse the full rankings.